Clinical trial
The Product Surveillance Registry REVERSE Post Approval Study
NCT01660035
Study timeline
Study start (actual)2012-04-01Date precision: month
Registry last updated2022-04-18
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Heart Failureunresolved
Interventions
Sponsors & collaborators
Medtroniclead sponsor
Mapped research locations
New YorkNew York, United States1HoustonTexas, United States1Los AngelesCalifornia, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1AtlantaGeorgia, United States1San AntonioTexas, United States1NashvilleTennessee, United States1ClevelandOhio, United States1PittsburghPennsylvania, United States1BirminghamAlabama, United States1CincinnatiOhio, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01660035 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.